Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of CMS-D001 in moderate to severe atopic dermatitis
ChiCTR2600119266Phase 2Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CMS-D001 in atopic dermatitis (AD) (4 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Proportion of participants achieving EASI 75 at Week 12. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
CMS-D001
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2600119266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119266.